Combivir
Product Images NDC 53808-0895

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Combivir (NDC 53808-0895). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by State Of Florida Doh Central Pharmacy, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image For 150mg / 300mg (150mg 300mg Health)

Label for COMBIVIR 150MG/300MG tablets showing a quantity of 30 tablets. The label includes the lot number, expiration date of 07/31/2013, and indicates it is for prescription use only. The labeler is State of Florida DOH Central Pharmacy in Tallahassee, FL. A barcode and UPC are also present.*

FDA Label Image

Lamivudine Chemical Structure (D3ec5198 Cdff 456b Aa01 7c808381ef17 01)

Chemical structure diagram of the active ingredient in COMBIVIR, showing a nucleoside analog with a pyrimidine base (cytosine derivative) attached to a sugar moiety containing a sulfur atom and a hydroxyl group.*

FDA Label Image

Zidovudine Chemical Structure (D3ec5198 Cdff 456b Aa01 7c808381ef17 02)

Chemical structure of the active ingredient in COMBIVIR as shown, depicting a nucleoside analog with a modified sugar moiety and azido group.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.